Follow
Sokratis G Papageorgiou, MD, PhD, FEAN, FANA
Sokratis G Papageorgiou, MD, PhD, FEAN, FANA
Associate Professor, Medical School National and Kapodistrian University of Athens
Verified email at med.uoa.gr
Title
Cited by
Cited by
Year
Current and future treatments for Alzheimer’s disease
KG Yiannopoulou, SG Papageorgiou
Therapeutic advances in neurological disorders 6 (1), 19-33, 2013
7412013
Current and future treatments in Alzheimer disease: an update
KG Yiannopoulou, SG Papageorgiou
Journal of central nervous system disease 12, 1179573520907397, 2020
6222020
A review of physical and cognitive interventions in aging
PD Bamidis, AB Vivas, C Styliadis, C Frantzidis, M Klados, W Schlee, ...
Neuroscience & Biobehavioral Reviews 44, 206-220, 2014
4092014
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ...
The Lancet Neurology 19 (2), 145-156, 2020
2332020
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: consensus from an …
P Odin, KR Chaudhuri, JT Slevin, J Volkmann, E Dietrichs, ...
Parkinsonism & Related Disorders 21 (10), 1133-1144, 2015
215*2015
Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder
PD Bamidis, P Fissler, SG Papageorgiou, V Zilidou, EI Konstantinidis, ...
Frontiers in aging neuroscience 7, 152, 2015
1992015
A normative study of the trail making test A and B in Greek adults
I Zalonis, E Kararizou, NI Triantafyllou, E Kapaki, S Papageorgiou, ...
The Clinical Neuropsychologist 22 (5), 842-850, 2008
1792008
Structural and functional impairment of the retina and optic nerve in Alzheimer's disease
M M Moschos, I Markopoulos, I Chatziralli, A Rouvas, S G Papageorgiou, ...
Current Alzheimer Research 9 (7), 782-788, 2012
1462012
The impact of COVID‐19 pandemic on people with mild cognitive impairment/dementia and on their caregivers
A Tsapanou, JD Papatriantafyllou, K Yiannopoulou, D Sali, F Kalligerou, ...
International Journal of Geriatric Psychiatry 36 (4), 583-587, 2021
1392021
Is interictal temporal hypometabolism related to mesial temporal sclerosis? A positron emission tomography/magnetic resonance imaging confrontation
F Semah, M Baulac, D Hasboun, V Frouin, JF Mangin, S Papageorgiou, ...
Epilepsia 36 (5), 447-456, 1995
1361995
The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for …
A Costa, T Bak, P Caffarra, C Caltagirone, M Ceccaldi, F Collette, ...
Alzheimer's research & therapy 9, 1-15, 2017
1092017
The effects of a computer-based cognitive and physical training program in a healthy and mildly cognitive impaired aging sample
F González-Palau, M Franco, P Bamidis, R Losada, E Parra, ...
Aging & Mental Health 18 (7), 838-846, 2014
1082014
Nonepisodic memory deficits in amnestic MCI
A Economou, SG Papageorgiou, C Karageorgiou, D Vassilopoulos
Cognitive and Behavioral Neurology 20 (2), 99-106, 2007
982007
Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau
NF Darwich, JM Phan, B Kim, ER Suh, JD Papatriantafyllou, L Changolkar, ...
Science 370 (6519), eaay8826, 2020
962020
Rapidly progressive dementia: causes found in a Greek tertiary referral center in Athens
SG Papageorgiou, T Kontaxis, A Bonakis, G Karahalios, N Kalfakis, ...
Alzheimer Disease & Associated Disorders 23 (4), 337-346, 2009
782009
Genetic assessment of familial and early‐onset Parkinson's disease in a Greek population
M Bozi, D Papadimitriou, R Antonellou, M Moraitou, M Maniati, ...
European journal of neurology 21 (7), 963-968, 2014
732014
Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration
E Kapaki, GP Paraskevas, SG Papageorgiou, A Bonakis, N Kalfakis, ...
Alzheimer Disease & Associated Disorders 22 (1), 47-53, 2008
722008
A novel SNCA A30G mutation causes familial Parkinsonʼs disease
H Liu, C Koros, T Strohäker, C Schulte, M Bozi, S Varvaresos, ...
Movement Disorders 36 (7), 1624-1633, 2021
712021
Motor and nonmotor features of carriers of the p. A53T alpha‐synuclein mutation: a longitudinal study
D Papadimitriou, R Antonelou, M Miligkos, M Maniati, N Papagiannakis, ...
Movement Disorders 31 (8), 1226-1230, 2016
692016
CSF biomarker profile and diagnostic value in vascular dementia
GP Paraskevas, E Kapaki, SG Papageorgiou, N Kalfakis, E Andreadou, ...
European Journal of Neurology 16 (2), 205-211, 2009
612009
The system can't perform the operation now. Try again later.
Articles 1–20